Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 1
1980 1
1981 1
1982 1
1984 2
1985 1
1986 3
1987 3
1988 4
1989 3
1990 4
1991 4
1992 6
1993 1
1994 4
1995 6
1996 9
1997 14
1998 15
1999 15
2000 27
2001 33
2002 39
2003 43
2004 51
2005 65
2006 71
2007 77
2008 92
2009 101
2010 115
2011 141
2012 130
2013 148
2014 150
2015 139
2016 138
2017 139
2018 139
2019 161
2020 160
2021 211
2022 182
2023 178
2024 153
2025 222
2026 40

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,882 results

Results by year

Filters applied: . Clear all
Page 1
Intensive vs Conventional Blood Pressure Lowering After Endovascular Thrombectomy in Acute Ischemic Stroke: The OPTIMAL-BP Randomized Clinical Trial.
Nam HS, Kim YD, Heo J, Lee H, Jung JW, Choi JK, Lee IH, Lim IH, Hong SH, Baik M, Kim BM, Kim DJ, Shin NY, Cho BH, Ahn SH, Park H, Sohn SI, Hong JH, Song TJ, Chang Y, Kim GS, Seo KD, Lee K, Chang JY, Seo JH, Lee S, Baek JH, Cho HJ, Shin DH, Kim J, Yoo J, Lee KY, Jung YH, Hwang YH, Kim CK, Kim JG, Lee CJ, Park S, Lee HS, Kwon SU, Bang OY, Anderson CS, Heo JH; OPTIMAL-BP Trial Investigators. Nam HS, et al. Among authors: kim jg. JAMA. 2023 Sep 5;330(9):832-842. doi: 10.1001/jama.2023.14590. JAMA. 2023. PMID: 37668619 Free PMC article. Clinical Trial.
Helicobacter pylori antibiotic resistance: a global challenge in search of solutions.
Schulz C, Liou JM, Alboraie M, Bornschein J, Campos Nunez C, Coelho LG, Quach DT, Fallone CA, Chen YC, Gerhard M, Gisbert JP, Jung HY, Katelaris PH, Kim JG, Lu H, Macke L, Mahachai V, Moss SF, Remes Troche JM, Riquelme A, Romano M, Setshedi M, Smith S, Suerbaum S, Tshibangu-Kabamba E, Vilaichone RK, Yadegar A, Yamaoka Y, Mégraud F, El-Omar EM, Sugano K, Malfertheiner P. Schulz C, et al. Among authors: kim jg. Gut. 2025 Sep 8;74(10):1561-1570. doi: 10.1136/gutjnl-2025-335523. Gut. 2025. PMID: 40645767
Adjuvant nivolumab plus chemotherapy versus placebo plus chemotherapy for stage III gastric or gastro-oesophageal junction cancer after gastrectomy with D2 or more extensive lymph-node dissection (ATTRACTION-5): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Kang YK, Terashima M, Kim YW, Boku N, Chung HC, Chen JS, Ji J, Yeh TS, Chen LT, Ryu MH, Kim JG, Omori T, Rha SY, Kim TY, Ryu KW, Sakuramoto S, Nishida Y, Fukushima N, Yamada T, Bai LY, Hirashima Y, Hagihara S, Nakada T, Sasako M. Kang YK, et al. Among authors: kim jg. Lancet Gastroenterol Hepatol. 2024 Aug;9(8):705-717. doi: 10.1016/S2468-1253(24)00156-0. Epub 2024 Jun 18. Lancet Gastroenterol Hepatol. 2024. PMID: 38906161 Clinical Trial.
Erratum.
Baek CH, Kim JG, Kim BT, Lim C, Kim SJ. Baek CH, et al. Among authors: kim jg. Bone Joint J. 2026 Feb 1;108-B(2):267. doi: 10.1302/0301-620X.108B2.BJJ-2025-00063. Bone Joint J. 2026. PMID: 41619800 No abstract available.
Bemarituzumab plus mFOLFOX6 as first-line treatment in East Asian patients with FGFR2b-overexpressing locally advanced or metastatic gastric/gastroesophageal junction cancer: subgroup of FIGHT final analysis.
Kang YK, Qin S, Lee KW, Oh SC, Kim IH, Kim JG, Li Y, Yan Z, Li J, Bai LY, Chan C, Yusuf A, Zahlten-Kümeli A, Taylor K, Yamaguchi K. Kang YK, et al. Among authors: kim jg. Gastric Cancer. 2024 Sep;27(5):1046-1057. doi: 10.1007/s10120-024-01516-3. Epub 2024 Jun 11. Gastric Cancer. 2024. PMID: 38861192 Free PMC article. Clinical Trial.
Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY.
Kang YK, Kim HD, Yook JH, Park YK, Lee JS, Kim YW, Kim JY, Ryu MH, Rha SY, Chung IJ, Kim IH, Oh SC, Park YS, Cheong JH, Jeong O, Heo MH, Kim HK, Park C, Yoo CH, Kang SY, Zang DY, Jang YJ, Sul JY, Kim JG, Kim BS, Beom SH, Hwang JE, Ryu SW, Kook MC, Ryoo BY, Kim H, Yoo MW, Lee NS, Lee SH, Noh SH. Kang YK, et al. Among authors: kim jg. J Clin Oncol. 2024 Sep 1;42(25):2961-2965. doi: 10.1200/JCO.23.02167. Epub 2024 Jul 12. J Clin Oncol. 2024. PMID: 38996201 Clinical Trial.
Contemporary Statistics of Acute Ischemic Stroke and Transient Ischemic Attack in 2021: Insights From the CRCS-K-NIH Registry.
Kim DY, Park TH, Cho YJ, Park JM, Lee K, Lee M, Lee J, Bae SY, Hong DY, Jung H, Ko E, Guk HS, Kim BJ, Kim JY, Kang J, Han MK, Park SS, Hong KS, Park HK, Lee JY, Lee BC, Yu KH, Oh MS, Kim DE, Gwak DS, Lee SJ, Kim JG, Lee J, Kwon DH, Cha JK, Kim DH, Kim JT, Choi KH, Kim H, Choi JC, Kim JG, Kang CH, Sohn SI, Hong JH, Park H, Lee SH, Kim C, Shin DI, Yum KS, Kang K, Park KY, Jeong HB, Park CY, Lee KJ, Kwon JH, Kim WJ, Lee JS, Bae HJ; CRCS-K Investigators. Kim DY, et al. Among authors: kim jg. J Korean Med Sci. 2024 Sep 2;39(34):e278. doi: 10.3346/jkms.2024.39.e278. J Korean Med Sci. 2024. PMID: 39228188 Free PMC article. Review.
2,882 results